Deciphering Pseudoendocrine Sarcoma: a clinicopathological, molecular and epigenetic study suggesting biological links with Solid Pseudopapillary Neoplasm of the Pancreas

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Pseudoendocrine sarcoma (PS) is a recently identified neoplasm with uncertain differentiation.
• It is characterized by recurrent CTNNB1 mutations, paravertebral location, and neuroendocrine-like histomorphology.

Purpose of the Study:

• To comprehensively analyze the clinicopathologic, immunohistochemical, transcriptomic, and epigenetic features of PS.
• To investigate potential biological relationships between PS and other tumor types, particularly Solid pseudopapillary neoplasm of the pancreas (SPNP).

Main Methods:

• Analysis of twelve PS cases including histopathology, immunohistochemistry, methylation profiling, and transcriptomic analysis.
• Comparison with existing methylation classes and transcriptomic datasets.

Main Results:

• PS tumors exhibited characteristic histomorphology with aberrant nuclear beta-catenin and CD56, S100 expression, and CTNNB1 mutations.
• Methylation profiling clustered PS with SPNP, distinct from other sarcomas and paragangliomas.
• Transcriptomic analysis revealed enrichment in Wnt signaling pathway genes and upregulation of fetal neuronal and epithelial lineage genes.

Conclusions:

• This study provides a detailed characterization of PS, expanding knowledge of this rare sarcoma.
• Findings suggest a biological link between PS and SPNP, potentially indicating a shared cell of origin.
• PS demonstrates distinct molecular features warranting further investigation for targeted therapies.